AMERICA

Moderna Says It Won’t Enforce COVID-19 Vaccine Patents During Pandemic

Google LogoMark Us Preferred on Google
Moderna Says It Won’t Enforce COVID-19 Vaccine Patents During Pandemic
A subject receives a shot in the first-stage safety study clinical trial of a potential vaccine by Moderna for COVID-19 at the Kaiser Permanente Washington Health Research Institute in Seattle, Wash., on March 16, 2020. Ted S. Warren/AP Photo
Tom Ozimek
Tom Ozimek
Reporter
|Updated:

Biotech company Moderna, which is conducting a late-stage trial for its experimental COVID-19 vaccine candidate, said it won’t enforce any patents related to its work for the duration of the pandemic.

The Massachusetts-based company said in an Oct. 8 statement that it “feels a special obligation under the current circumstances to use our resources to bring this pandemic to an end as quickly as possible” and won’t enforce its COVID-19-related rights against vaccine makers using its product to fight the CCP (Chinese Communist Party) virus outbreak.
Google LogoMark Us Preferred on Google
Tom Ozimek
Tom Ozimek
Reporter
Tom Ozimek is a senior reporter for The Epoch Times. He has a broad background in journalism, deposit insurance, marketing and communications, and adult education.
twitter
Related Topics